Jun-Sung Moon

25PUBLICATIONS
59CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Nutritional epidemiologyEpidemiological modellingMajor global burdens of diseaseMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Feb 03, 2026
Efficacy and safety of adding a fourth oral antidiabetic drug versus metformin dose escalation in patients with type 2 diabetes inadequately controlled on triple oral combination therapy (EFFORT): A 24-week, randomized, open-label, multicenter trial.

So Ra Kim, Jun Hwa Hong, Sin Gon Kim

|Jun 10, 2025
Low Thyrotropin Levels Are Associated With an Increased Risk of Atherosclerotic Cardiovascular Disease in Euthyroid Individuals: The Korea National Health and Nutrition Examination Survey 2013-2015.

Jin-Woo Kim, Han-Joon Bae, Jun Sung Moon

|Jan 09, 2025
Effect of Glomerular Hyperfiltration on Incident Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus.

Seung Min Chung, Inha Jung, Da Young Lee

|Jan 03, 2025
Risk acceleration by gout on major adverse cardiovascular events and all-cause death in patients with diabetes and chronic kidney disease.

Da Young Lee, Jun Sung Moon, Inha Jung

|Jun 10, 2024
Efficacy and tolerability of initial triple combination therapy with metformin, dapagliflozin and saxagliptin compared with stepwise add-on therapy in drug-naïve patients with type 2 diabetes (TRIPLE-AXEL study): A multicentre, randomized, 104-week, open-label, active-controlled trial.

Nam Hoon Kim, Jun Sung Moon, Yong-Ho Lee

|May 07, 2024
Mitochondrial ALDH2 improves ß-cell survival and function against doxorubicin-induced apoptosis by targeting CK2 signaling.

Udayakumar Karunakaran, Eun Yeong Ha, Suma Elumalai

Pageof 5

Frequent Collaborators

8 joint publications

Seung Min Chung

7 joint publications

Kyu-Chang Won

3 joint publications

Sin Gon Kim

3 joint publications

Soo Lim